Ovid Therapeutics Inc (OVID)
3.15
-0.12
(-3.82%)
USD |
NASDAQ |
May 17, 16:00
3.15
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Price to Book Value: 2.855 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.855 |
| May 16, 2024 | 2.968 |
| May 15, 2024 | 3.009 |
| May 14, 2024 | 2.927 |
| May 13, 2024 | 2.737 |
| May 10, 2024 | 2.719 |
| May 09, 2024 | 2.759 |
| May 08, 2024 | 2.795 |
| May 07, 2024 | 2.714 |
| May 06, 2024 | 2.732 |
| May 03, 2024 | 2.768 |
| May 02, 2024 | 2.777 |
| May 01, 2024 | 2.768 |
| April 30, 2024 | 2.759 |
| April 29, 2024 | 3.021 |
| April 26, 2024 | 2.804 |
| April 25, 2024 | 2.705 |
| April 24, 2024 | 2.850 |
| April 23, 2024 | 2.895 |
| April 22, 2024 | 2.850 |
| April 19, 2024 | 2.922 |
| April 18, 2024 | 2.904 |
| April 17, 2024 | 2.813 |
| April 16, 2024 | 2.868 |
| April 15, 2024 | 2.895 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.895 |
| April 11, 2024 | 2.958 |
| April 10, 2024 | 2.877 |
| April 09, 2024 | 2.931 |
| April 08, 2024 | 2.912 |
| April 05, 2024 | 2.939 |
| April 04, 2024 | 2.758 |
| April 03, 2024 | 2.758 |
| April 02, 2024 | 2.758 |
| April 01, 2024 | 2.794 |
| March 31, 2024 | |
| March 28, 2024 | 2.456 |
| March 27, 2024 | 2.456 |
| March 26, 2024 | 2.416 |
| March 25, 2024 | 2.489 |
| March 22, 2024 | 2.577 |
| March 21, 2024 | 2.456 |
| March 20, 2024 | 2.247 |
| March 19, 2024 | 2.215 |
| March 18, 2024 | 2.199 |
| March 15, 2024 | 2.191 |
| March 14, 2024 | 2.215 |
| March 13, 2024 | 2.271 |
| March 12, 2024 | 2.279 |
| March 11, 2024 | 2.368 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7143
Minimum
Nov 07 2022
15.43
Maximum
Aug 19 2020
2.880
Average
2.070
Median
May 09 2023
Price to Book Value Benchmarks
| Ligand Pharmaceuticals Inc | 1.917 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
| Theriva Biologics Inc | 0.204 |
Price to Book Value Related Metrics
| PS Ratio | 469.90 |
| Price | 3.15 |
| Earnings Yield | -23.17% |
| Market Cap | 223.48M |